Company news
Amarantus Bioscience Holdings, Inc. (OTC:AMBS) news
Amarantus Bioscience Holdings, Inc. news releases on 6ix. Latest, Dec 4, 2019: Amarantus Subsidiary Elto Pharma Receives Notice of Allowance Covering Use…
Press releases — page 2
Amarantus Subsidiary Elto Pharma Receives Notice of Allowance Covering Use of Eltoprazine Combined with CBD to Treat Parkinson’s Disease
December 4, 2019
Amarantus Announces Issuance of Chinese Patent Covering the Use of MANF and CDNF in Retinal Disorders for Subsidiary MANF Therapeutics
November 21, 2019
Amarantus Provides Recapitalization Update to Shareholders
November 18, 2019
Todos and Amarantus JV Announces Full Enrollment for Clinical Trial of LymPro Alzheimer’s Blood Test Relationship with Amyloid PET
November 14, 2019
Emerald Organic Products to License Therapeutics Portfolio from Amarantus Bioscience Holdings
October 25, 2019
Amarantus Enters Into Agreement to License Diverse Therapeutics Portfolio to CBD-focused Emerald Organic Products
October 24, 2019
Todos Medical to Present at Dawson James Small Cap Growth Conference
October 24, 2019
Todos Medical and Orot+ Announce First Patient Enrolled in Pre-Commercial Launch Preparations of TM-B1 and TM-B2 Breast Cancer Blood Screening Tests in Europe
September 24, 2019
Todos Medical Signs Binding Term Sheet with HWH World for Network Marketing of Blood Tests for the Early Detection of Breast Cancer
September 13, 2019
Todos Medical Enters into MOU to Expand Existing Early Detection Breast Cancer Blood Test Distribution Partnership with Orot+ into Japan
September 3, 2019
Todos Medical Appoints Dr. Jorge Leon as Medical Advisor
August 6, 2019
Todos Medical Announces Positive Alzheimer's Biomarker Clinical Data from LymPro vs. Amyloid PET Interim Analysis
July 15, 2019
Todos Medical to Appoint Dr. Paula Trzepacz As Chief Medical Officer And Files New Patent Application
July 12, 2019
Todos Medical Announces Launch of Public Offering
July 11, 2019
Todos Medical to Sponsor the Investacure ‘Cure Coin Awards Reception’ for Alzheimer’s and CTE Research at AAIC 2019 in Los Angeles
June 27, 2019
Amarantus Enters into Letter of Intent with The Alchemists Kitchen to Establish Joint Venture for Research and Commercialization of Hemp and Herbal Smokables for Addiction Treatment Including Smoking Cessation
June 25, 2019
Amarantus Announces Positive Pre-Clinical Data for MANF in Wolfram Syndrome Presented at the 79th Annual Scientific Sessions of the American Diabetes Association
June 18, 2019
Todos Medical CEO Presented Corporate Update And Roadmap at The LD Micro Conference
June 17, 2019
Amarantus Announces Issuance of US Patent No. 10,195,251 Covering MANF Treatment of Wolfram's Syndrome, Retinitis Pigmentosa, and Glaucoma for Subsidiary MANF Therapeutics
June 13, 2019
Amarantus to Present at 9th Annual LD Micro Invitational Conference
June 4, 2019
Amarantus Engages Evolution Venture Partners to Evaluate Strategic Alternatives for Expansion into the Emerging Legal Hemp Industry
May 28, 2019
Todos Medical Exercises Option to Acquire Remaining 80.01% of Breakthrough Diagnostics from Amarantus After Review of Alzheimer's Blood Test Data
May 28, 2019
Todos Medical Receives Approval from Israeli Ministry of Health (AMAR) to Market and Sell its Breast Cancer Screens in Israel
May 23, 2019
Todos Medical Enters Exclusive Distribution Agreement with Care G.B. Plus, Ltd. for its Breast Cancer Screening Tests in Israel
May 21, 2019
Todos Medical Announces Voting Results from 2019 Annual Shareholder Meeting
May 3, 2019
Todos Medical Receives Notice of Allowance from the USPTO Covering the Early Diagnosis of Lung Cancer Using the Todos Biochemical Infrared Analysis (TBIA)
May 1, 2019
Todos Medical Enters Into Definitive Agreement With Orot+ for Exclusive Distribution Rights of its Breast Cancer Screening Tests in 2 European Countries
April 15, 2019
Todos Medical Raises $1,350,500 In Funding and Finalizes Joint Venture Agreement with Amarantus Bioscience
February 28, 2019
MANF Therapeutics Receives Notices of Allowance Covering MANF Use as Treatment for Parkinson's in Europe and Diabetes in Japan
January 17, 2019
MANF Therapeutics Receives Notice of Allowance from US Patent & Trademark Office Covering the Use of MANF or CDNF as a Treatment for Glaucoma, Macular Degeneration and Retinitis Pigmentosa
January 15, 2019
Amarantus Announces Commercialization Partnership With IDEA Pharma for Subsidiaries
January 11, 2019
Amarantus Provides 2019 Roadmap
January 7, 2019
Todos Medical Enters into Joint Venture Agreement with Amarantus to develop Alzheimer’s Blood Diagnostic LymPro Test 2.0
December 3, 2018
Coeptis Pharma Enters into Agreement to Acquire Elto Pharma
November 28, 2018
Withdrawal of JV Offer
October 23, 2018
Term Sheet in Support of JV
October 19, 2018
Joint Venture Offer
October 18, 2018
Amarantus Provides Corporate Update
July 20, 2018
MANF Therapeutics Announces Positive MANF Pre-Clinical Data inAlpha-Synuclein Model of Parkinson's DiseasePublished in Peer-Reviewed Journal Experimental Neurobiology
July 9, 2018
Amarantus Exercises Exclusive Option with Leipzig University for Alzheimer's Blood Diagnostic "LymPro Test 2.0"
May 30, 2018
Amarantus to Present at LD Micro and The Reg A Conference
May 24, 2018
Amarantus Retains Weild & Co. to Advise on JOBS Act Funding
May 22, 2018
MANF Therapeutics Announces Publication in Society for Neuroscience eNeuro Journal of Human Ocular Distribution and Animal Photoreceptor Protection Data for MANF
May 21, 2018
Amarantus Provides Business Overview
May 11, 2018
Amarantus Enters into Exclusive Option Agreement with Leipzig University to License IP Covering Alzheimer's Blood Diagnostic LymPro Test 2.0 Blood Test vs. Amyloid PET
May 4, 2018
MANF Therapeutics Announces Issuance of Patent in Hong Kong Covering Use of MANF for Treatment of Diabetes and Wolfram's
May 3, 2018
Elto Pharma Receives Notice of Allowance in Canada for Patent Covering Use of Eltoprazine to Treat non-ADHD Cognitive Impairment
May 1, 2018
Elto PharmaAppoints Paula Trzepacz, MD asChief Medical Advisor
April 30, 2018
Cutanogen Appoints Richard Kagan, MD as Chief Medical Advisor
April 23, 2018
Amarantus to Present at the Planet MicroCap Showcase 2018 in Las Vegas
April 19, 2018